Home/UKMLA Revision/Drug-induced gingival hyperplasia
Pharmacology1 UKMLA question

Drug-induced gingival hyperplasia — UKMLA Revision Notes

Drug-induced gingival hyperplasia is an important clinical condition in Pharmacology that is tested in the UKMLA Applied Knowledge Test (AKT). Medical students and doctors preparing for the UKMLA or PLAB 1 must understand the pathophysiology, clinical presentation, investigations, and evidence-based management of Drug-induced gingival hyperplasia as outlined in current NICE guidelines.

Key Facts

  • Drug-induced gingival hyperplasia is a key condition on the GMC UKMLA Content Map
  • Commonly tested in the Pharmacology section of the UKMLA Applied Knowledge Test
  • Understand the pathophysiology, clinical features, investigations, and management
  • NICE guidelines provide the evidence base for management decisions
  • Consider differential diagnoses and red flag symptoms in clinical scenarios

Investigations

  • Drug levels (if applicable)
  • FBC, U&E, LFTs
  • ECG (QTc)
  • Renal function
  • Liver function
  • Medication reconciliation

Management

  • Review and rationalise medications
  • Dose adjustment for renal/hepatic impairment
  • Monitor for drug interactions and adverse effects
  • Patient counselling on medication adherence
  • Pharmacist review
  • Prescribing safety checks

Practice 1+ Drug-induced gingival hyperplasia Questions

Test your knowledge with SBA questions on Drug-induced gingival hyperplasia and all 430 UKMLA Content Map conditions. Instant feedback, NICE guideline explanations, and spaced repetition included.